338 related articles for article (PubMed ID: 26780721)
1. Inverse correlation of expression of microRNA-140-5p with progression of multiple sclerosis and differentiation of encephalitogenic T helper type 1 cells.
Guan H; Singh UP; Rao R; Mrelashvili D; Sen S; Hao H; Zumbrun EE; Singh NP; Nagarkatti PS; Nagarkatti M
Immunology; 2016 Apr; 147(4):488-98. PubMed ID: 26780721
[TBL] [Abstract][Full Text] [Related]
2. miR-326 and miR-26a, two potential markers for diagnosis of relapse and remission phases in patient with relapsing-remitting multiple sclerosis.
Honardoost MA; Kiani-Esfahani A; Ghaedi K; Etemadifar M; Salehi M
Gene; 2014 Jul; 544(2):128-33. PubMed ID: 24792898
[TBL] [Abstract][Full Text] [Related]
3. miR-141 and miR-200a, Revelation of New Possible Players in Modulation of Th17/Treg Differentiation and Pathogenesis of Multiple Sclerosis.
Naghavian R; Ghaedi K; Kiani-Esfahani A; Ganjalikhani-Hakemi M; Etemadifar M; Nasr-Esfahani MH
PLoS One; 2015; 10(5):e0124555. PubMed ID: 25938517
[TBL] [Abstract][Full Text] [Related]
4. pSTAT1, pSTAT3, and T-bet expression in peripheral blood mononuclear cells from relapsing-remitting multiple sclerosis patients correlates with disease activity.
Frisullo G; Angelucci F; Caggiula M; Nociti V; Iorio R; Patanella AK; Sancricca C; Mirabella M; Tonali PA; Batocchi AP
J Neurosci Res; 2006 Oct; 84(5):1027-36. PubMed ID: 16865709
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-142 regulates inflammation and T cell differentiation in an animal model of multiple sclerosis.
Talebi F; Ghorbani S; Chan WF; Boghozian R; Masoumi F; Ghasemi S; Vojgani M; Power C; Noorbakhsh F
J Neuroinflammation; 2017 Mar; 14(1):55. PubMed ID: 28302134
[TBL] [Abstract][Full Text] [Related]
6. Altered expression of miR-17-5p in CD4+ lymphocytes of relapsing-remitting multiple sclerosis patients.
Lindberg RL; Hoffmann F; Mehling M; Kuhle J; Kappos L
Eur J Immunol; 2010 Mar; 40(3):888-98. PubMed ID: 20148420
[TBL] [Abstract][Full Text] [Related]
7. Next-generation sequencing reveals broad down-regulation of microRNAs in secondary progressive multiple sclerosis CD4+ T cells.
Sanders KA; Benton MC; Lea RA; Maltby VE; Agland S; Griffin N; Scott RJ; Tajouri L; Lechner-Scott J
Clin Epigenetics; 2016; 8(1):87. PubMed ID: 27570566
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Expression Levels of miR-29b-3p and miR-326 in T Helper-1 and T Helper-17 Cells Isolated from Responsive and Non-responsive Relapsing-remitting Multiple Sclerosis Patients Treated with Interferon-beta.
Karimi L; Eskandari N; Shaygannejad V; Zare N; Andalib A; Khanahmad H; Mirmosayyeb O
Iran J Allergy Asthma Immunol; 2020 Aug; 19(4):416-425. PubMed ID: 33463108
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of miR-125a-5p and miR-218-5p in Peripheral Blood Mononuclear Cells of Patients with Relapsing-Remitting Multiple Sclerosis.
Mosarrezaii Aghdam A; Rezaei S; Zarza Nalivan F; Babaie F; Amiri Nikpour MR; Torkamandi S
Immunol Invest; 2022 Jul; 51(5):1149-1161. PubMed ID: 33866949
[TBL] [Abstract][Full Text] [Related]
10. miR-140-5p regulates T cell differentiation and attenuates experimental autoimmune encephalomyelitis by affecting CD4
Zhu S; Zhang X; Guan H; Huang F; Wu L; Hou D; Zheng Z; Yu M; Huang L; Ge L
Int Immunopharmacol; 2019 Oct; 75():105778. PubMed ID: 31494340
[TBL] [Abstract][Full Text] [Related]
11. Circulating microRNA Expression Profiling Identifies miR-125a-5p Promoting T Helper 1 Cells Response in the Pathogenesis of Hashimoto's Thyroiditis.
Liu Y; Ding X; Xiong S; Wang X; Tang X; Wang L; Wang S; Peng H
Front Immunol; 2020; 11():1195. PubMed ID: 32595646
[TBL] [Abstract][Full Text] [Related]
12. miR-27a and miR-214 exert opposite regulatory roles in Th17 differentiation via mediating different signaling pathways in peripheral blood CD4+ T lymphocytes of patients with relapsing-remitting multiple sclerosis.
Ahmadian-Elmi M; Bidmeshki Pour A; Naghavian R; Ghaedi K; Tanhaei S; Izadi T; Nasr-Esfahani MH
Immunogenetics; 2016 Jan; 68(1):43-54. PubMed ID: 26563334
[TBL] [Abstract][Full Text] [Related]
13. Regulation of the MIR155 host gene in physiological and pathological processes.
Elton TS; Selemon H; Elton SM; Parinandi NL
Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of miR-155 in CD4(+) T Cells Promoted Th1 Bias in Patients With Unstable Angina.
Chen Y; Li L; Lu Y; Su Q; Sun Y; Liu Y; Yang D
J Cell Physiol; 2015 Oct; 230(10):2498-509. PubMed ID: 25760478
[TBL] [Abstract][Full Text] [Related]
15. Posttranscriptional Interaction Between miR-450a-5p and miR-28-5p and STAT1 mRNA Triggers Osteoblastic Differentiation of Human Mesenchymal Stem Cells.
Dernowsek JA; Pereira MC; Fornari TA; Macedo C; Assis AF; Donate PB; Bombonato-Prado KF; Passos-Bueno MR; Passos GA
J Cell Biochem; 2017 Nov; 118(11):4045-4062. PubMed ID: 28407302
[TBL] [Abstract][Full Text] [Related]
16. Linc-MAF-4 regulates Th1/Th2 differentiation and is associated with the pathogenesis of multiple sclerosis by targeting MAF.
Zhang F; Liu G; Wei C; Gao C; Hao J
FASEB J; 2017 Feb; 31(2):519-525. PubMed ID: 27756768
[TBL] [Abstract][Full Text] [Related]
17. Let-7f-5p suppresses Th17 differentiation via targeting STAT3 in multiple sclerosis.
Li ZH; Wang YF; He DD; Zhang XM; Zhou YL; Yue H; Huang S; Fu Z; Zhang LY; Mao ZQ; Li S; Zhang CY; Chen X; Fu J
Aging (Albany NY); 2019 Jul; 11(13):4463-4477. PubMed ID: 31326963
[TBL] [Abstract][Full Text] [Related]
18. miR-455-5p downregulation promotes inflammation pathways in the relapse phase of relapsing-remitting multiple sclerosis disease.
Torabi S; Tamaddon M; Asadolahi M; Shokri G; Tavakoli R; Tasharrofi N; Rezaei R; Tavakolpour V; Sazegar H; Kouhkan F
Immunogenetics; 2019 Feb; 71(2):87-95. PubMed ID: 30310937
[TBL] [Abstract][Full Text] [Related]
19. Elevated gene expression of Th1/Th2 associated transcription factors is correlated with disease activity in patients with systemic lupus erythematosus.
Lit LC; Wong CK; Li EK; Tam LS; Lam CW; Lo YM
J Rheumatol; 2007 Jan; 34(1):89-96. PubMed ID: 17117487
[TBL] [Abstract][Full Text] [Related]
20. Exosomal microRNA signatures in multiple sclerosis reflect disease status.
Ebrahimkhani S; Vafaee F; Young PE; Hur SSJ; Hawke S; Devenney E; Beadnall H; Barnett MH; Suter CM; Buckland ME
Sci Rep; 2017 Oct; 7(1):14293. PubMed ID: 29084979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
